Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,283.9
3.9 (0.12%)

 

  • STI Straits Times Index
    3,283.9
    3.9 (0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,530.3
    -12.6 (-0.82%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,127.8
    15.1 (0.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,558.2
    -11.7 (-0.33%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,043.2M
  • Value: 1,204.6M
  • Rise: 113
  • Fall: 196
  • Unch: 451

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Shen Yao0.003-
DISA0.008-0.001
Sembcorp Marine0.083+0.001
Jiutian Chemical0.083+0.001
RH PetroGas0.189-0.002
Beverly JCG0.002-
ThaiBev0.640-
HGH0.012+0.001
Oceanus0.029-
Genting Sing0.780-

World Indices

World Indices
Name Last Change
Nasdaq 14,506.9 -386.9
HSI 24,127.8 +15.1
HSCEI 8,441.7 -7.3
Jakarta 6,592.0 -22.1
Nikkei 225 27,467.2 -790.0
SSE Comp 3,558.2 -11.7
Shanghai A 3,728.8 -12.3
Shanghai B 287.0
KOSPI 2,842.3 -22.0

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PENUMBRA INC PENUMBRA
Updated on 18 Jan 2022 (End of trading day)
Last (USD): 223.730 Change: -13.850 High: 236.025 Remarks: -
Change (%): -5.83 Low: 223.030
Open 234.920 Yesterday's Close 237.57999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 240,173 Cumulative Value

Company Background

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.42030 Trailing EPS (USD) b 0.89845 NAV (USD) c 18.4947
PE a - Trailing PE d 249.018 Price / NAV c 12.0970
Dividend Yield (%) e - Cash In Hand (USD) f 1.7744 Issued & Paid-up Shares g 37,358,800
Piotroski F Score 2 Market Cap (M) 8,358.284 Free Float (%) 94.3
Return on Equity (ROE) (%) h 4.858 Revenue Growth (%) TTM i 31.868
Net Earnings Growth (%) j 447.428 Net Debt/Equity k Net Cash
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 10 Nov 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --35.060
-13.55 %
10 Days --36.280
-13.95 %
20 Days --47.350
-17.47 %
Medium Term Return 3 Months --50.050
-18.28 %
6 Months --40.930
-15.47 %
1 Year --19.060
-7.85 %
Long Term Return 2 Years -+53.140
+31.15 %
3 Years -+84.500
+60.69 %
5 Years -+148.530
+197.51 %
Annualised Return Annualised --
+24.37 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PENUMBRA INC NYSE 8,358.284 - 249.018 12.0970 -
Industry Medical Specialties NYSE 38,216.066 40.352 27.042 4.5615 0.635
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 232,527.725 36.475 27.149 6.0069 0.150
Local Peer ABBOTT LABORATORIES NYSE 223,812.465 50.036 31.033 6.5020 1.211
Local Peer DANAHER CORP NYSE 206,084.007 58.713 36.016 5.1286 0.248
Local Peer MEDTRONIC PLC NYSE 144,526.754 40.079 30.718 2.7798 2.253
Local Peer STRYKER CORP NYSE 98,263.475 61.453 51.718 6.9307 0.901
Local Peer BECTON DICKINSON & CO NYSE 74,230.898 37.078 37.078 3.1354 1.288
Local Peer EDWARDS LIFESCIENCES CORP NYSE 72,316.607 87.827 48.952 13.0505 -
Local Peer BOSTON SCIENTIFIC CORP NYSE 63,013.058 - 60.473 3.8278 -
Local Peer AGILENT TECHNOLOGIES INC NYSE 42,422.080 35.060 35.060 7.8720 0.553
Local Peer BAXTER INTERNATIONAL INC NYSE 42,989.501 39.010 35.411 4.9019 1.122
Local Peer ALCON AG NYSE 38,931.627 - 117.264 2.0391 0.134
Local Peer RESMED INC NYSE 35,074.069 73.917 70.184 11.5907 0.673
Other Local Peers METTLER-TOLEDO INTERNATIONAL INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), STERIS PLC (NYSE), PERKINELMER INC (NYSE), WATERS CORP (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), QIAGEN NV (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), GLOBUS MED INC (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), STEVANATO GROUP S.P.A. (NYSE), CONMED CORP (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), GLAUKOS CORPORATION (NYSE), AVANOS MEDICAL INC (NYSE), PARAGON 28 INC (NYSE), BUTTERFLY NETWORK INC (NYSE), VICARIOUS SURGICAL INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), SONENDO INC (NYSE), INVACARE CORP (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 105,481.656 - - - -
Global Peer IDEXX LABORATORIES INC NASDAQ 43,937.500 75.523 58.052 58.2142 -
Global Peer DEXCOM INC NASDAQ 41,663.860 84.408 78.715 19.5046 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 38,603.324 21.737 52.163 10.9770 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 22,640.023 31.116 49.085 6.8246 -
Global Peer HOLOGIC INC NASDAQ 17,451.132 9.325 9.325 4.1367 -
Global Peer INSULET CORPORATION NASDAQ 16,145.245 2,374.239 - 32.4265 -
Global Peer ABIOMED INC NASDAQ 13,302.559 58.985 89.188 9.6078 -
Global Peer MASIMO CORPORATION NASDAQ 12,350.333 51.395 53.221 8.4122 -
Global Peer FISHER & PAYKEL HEALTHCARE CORP ASX 16,472.701 33.653 33.760 10.8427 1.460
Other Global Peers DENTSPLY SIRONA INC (NASDAQ), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), TANDEM DIABETES CARE INC (NASDAQ), NOVOCURE LTD (NASDAQ), MICROPORT SCIENTIFIC CORPORATION (HKEx), SHANGHAI MICROPORT MEDBOT (GROUP) C (HKEx), SOTERA HEALTH CO (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), EBOS GROUP (ASX), QUIDEL CORP (NASDAQ), ANGELALIGN TECHNOLOGY INC (HKEx), ICU MEDICAL INC (NASDAQ), HARTA (Bursa), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), LIVANOVA PLC (NASDAQ), TOPGLOV (Bursa), Top Glove (SGX), NEOGEN CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), INARI MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CAREDX INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), HESKA CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CUE HEALTH INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), BIOLIFE SOLUTIONS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), NANOSONICS LIMITED (ASX), ALPHATEC HLDGS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), BIOVENTUS INC (NASDAQ), PEIJIA MEDICAL LIMITED (HKEx), TREACE MED CONCEPTS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), PULMONX CORPORATION (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), CERUS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AK MEDICAL HLDGS LTD (HKEx), PROCEPT BIOROBOTICS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VIEWRAY INC (NASDAQ), SUPERMX (Bursa), AIRSCULPT TECHNOLOGIES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SI BONE INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), INOGEN INC (NASDAQ), INTERCURE LTD (NASDAQ), CUTERA INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), NYXOAH SA (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), SISRAM MEDICAL LTD (HKEx), NANO-X IMAGING LTD (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), 908 DEVICES INC (NASDAQ), IRADIMED CORP (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), TRANSMEDICS GROUP INC (NASDAQ), DERMTECH INC (NASDAQ), STEREOTAXIS INC (NYSE American), LUMIRADX LTD (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), APYX MEDICAL CORPORATION (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), ACCURAY INCORPORATED (NASDAQ), AXOGEN INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), NEUROPACE INC (NASDAQ), AROA BIOSURGERY LTD (ASX), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), FLUIDIGM CORP DEL (NASDAQ), SHANGHAI CONANT OPTICAL CO LTD (HKEx), MEDICAL DEVELOPMENT INTL (ASX), APOLLO ENDOSURGERY INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), IMPEDIMED LIMITED (ASX), EARGO INC (NASDAQ), QUOTIENT LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CVRX INC (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), ATOSSA THERAPEUTICS INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), CORMEDIX INC (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), TELA BIO INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DARIOHEALTH CORP (NASDAQ), PAVMED INC (NASDAQ), MINERVA SURGICAL INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), LUCID DIAGNOSTICS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), INTRICOM CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), UGHealthcare (SGX), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), Medtecs Intl (SGX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CONFORMIS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SURGALIGN HOLDINGS INC (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), NEURONETICS INC (NASDAQ), ELECTROMED INC (NYSE American), ATOMO DIAGNOSTICS LIMITED (ASX), ICECURE MEDICAL LTD (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), RGTBHD (Bursa), VENUS CONCEPT INC (NASDAQ), MICRO-X LTD (ASX), IRIDEX CORP (NASDAQ), SDI LTD (ASX), ALPHA PRO TECH (NYSE American), VINCENT MEDICAL HOLDINGS LTD (HKEx), VOLITIONRX LIMITED (NYSE American), CLEANSPACE HOLDINGS LTD (ASX), OPTISCAN IMAGING (ASX), REWALK ROBOTICS LTD (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), KELFRED HOLDINGS LTD (HKEx), IMMUCELL CORP (NASDAQ), LENSAR INC (NASDAQ), INTEGRITY APPLICATIONS INCORPORATIO (NASDAQ), TITAN MEDICAL INC (NASDAQ), RESONANCE HEALTH LTD (ASX), ZOSANO PHARMA CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), BIOLASE INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), DIMERIX LTD (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ENVVENO MED CORP (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROCORE INC (NASDAQ), NEPHROS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), COMPUMEDICS (ASX), NUTRIBAND INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), DAXOR CORP (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), CARDIEX LTD (ASX), CELSION CORPORATION (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), NOVA EYE MEDICAL LIMITED (ASX), ADVENTA (Bursa), Yunnan Energy (SGX), SOLENO THERAPEUTICS INC (NASDAQ), Biolidics (SGX), NEUROMETRIX INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NEOVASC INC (NASDAQ), AVINGER INC (NASDAQ), APPLIED UV INC (NASDAQ), RESPIRI LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), AETHLON MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), HEARTBEAM INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), ADHERIUM LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), LKL (Bursa), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), METALICITY LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE GROUP LTD (HKEx), SINTX TECHNOLOGIES INC (NASDAQ), USCOM LTD (ASX), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), Annica (SGX), VIVEVE MEDICAL INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), NUWELLIS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RA MEDICAL SYSTEMS INC (NYSE American), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.